{"title":"Inteligencia artificial. ¡La palabra del año!","authors":"Mireya González Blanco","doi":"10.51288/00830103","DOIUrl":"https://doi.org/10.51288/00830103","url":null,"abstract":"","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49521366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diana Cegarra Meza, Albani Aular Barrios, Alexandra Rivero Fraute
Objective: To design a nomogram by percentiles of the fetal right liver lobe measurement in pregnant between 16 and 40 weeks of gestation who attend the Maternidad Concepción Palacios in the period between March and August 2020. Methods: A prospective, descriptive and cross-sectional study was conducted that included 350 patients with informed consent, were measured fetal right liver lobe, related to gestational age, based on the date of the last menstruation or ultrasound of the first trimester, and associated with weight, size and maternal body mass index. Results: An average fetal right liver lobe measurement of 37.42 ± 12.03 mm (Min 13 and max 62 mm) was obtained. The regression analysis yielded a correlation coefficient between fetal right liver lobe size and gestational age of 0.950. The determination coefficient obtained was 0.903. Depending on the result of the variance analysis, there is an association between the two variables (p-0.000). A fetal right liver lobe increase measurement of + 1,585 per week (95% CI - 1,531 - 1,640) (p-0.000) was obtained. The percentile nomogram was constructed. There was no relationship between the measurement and maternal weight and height, but there was with the body mass index. Conclusion: The fetal right liver lobe, as an expression of the liver measure, grows relative to the increase in gestational age and this allowed to design a nomogram per percentiles.
{"title":"Lóbulo hepático derecho fetal: nomograma por percentiles","authors":"Diana Cegarra Meza, Albani Aular Barrios, Alexandra Rivero Fraute","doi":"10.51288/00830108","DOIUrl":"https://doi.org/10.51288/00830108","url":null,"abstract":"Objective: To design a nomogram by percentiles of the fetal right liver lobe measurement in pregnant between 16 and 40 weeks of gestation who attend the Maternidad Concepción Palacios in the period between March and August 2020. Methods: A prospective, descriptive and cross-sectional study was conducted that included 350 patients with informed consent, were measured fetal right liver lobe, related to gestational age, based on the date of the last menstruation or ultrasound of the first trimester, and associated with weight, size and maternal body mass index. Results: An average fetal right liver lobe measurement of 37.42 ± 12.03 mm (Min 13 and max 62 mm) was obtained. The regression analysis yielded a correlation coefficient between fetal right liver lobe size and gestational age of 0.950. The determination coefficient obtained was 0.903. Depending on the result of the variance analysis, there is an association between the two variables (p-0.000). A fetal right liver lobe increase measurement of + 1,585 per week (95% CI - 1,531 - 1,640) (p-0.000) was obtained. The percentile nomogram was constructed. There was no relationship between the measurement and maternal weight and height, but there was with the body mass index. Conclusion: The fetal right liver lobe, as an expression of the liver measure, grows relative to the increase in gestational age and this allowed to design a nomogram per percentiles.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45160642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To determine the prevalence of contraception among fertile women in the municipality of Sabaneta and its possible associated factors. Methods: we performed a cross-sectional study on women of the municipality of Sabaneta, a stratified sampling was carried out by zone and age group, then a systematic sampling; 354 women were included. Data were collected through a survey. OR with its CI (95%) and Chi-squared test (X2) were used for data analysis with a significant p value <0.05. Results: the prevalence of contraception was 62%. Female sterilization was the most frequently used method (35.6%). Conclusion: the use of contraceptive methods among women in Sabaneta is lower than the national average and may be affected by age, marital status, educational level.
{"title":"Prevalencia de anticoncepción en mujeres en edad fértil de Sabaneta, Antioquia","authors":"J. E. Salazar Flórez, Á. P. Echeverri Rendón","doi":"10.51288/00830110","DOIUrl":"https://doi.org/10.51288/00830110","url":null,"abstract":"Objective: To determine the prevalence of contraception among fertile women in the municipality of Sabaneta and its possible associated factors. Methods: we performed a cross-sectional study on women of the municipality of Sabaneta, a stratified sampling was carried out by zone and age group, then a systematic sampling; 354 women were included. Data were collected through a survey. OR with its CI (95%) and Chi-squared test (X2) were used for data analysis with a significant p value <0.05. Results: the prevalence of contraception was 62%. Female sterilization was the most frequently used method (35.6%). Conclusion: the use of contraceptive methods among women in Sabaneta is lower than the national average and may be affected by age, marital status, educational level.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44744682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katiuska Ríos Calderón, Yeiry González,, Mónica Elizabeth Cabrera-Sosa,, Linder Mariano Díaz Colmenarez, Yohaina Haddad, Rómely del Valle Blanco Salazar, Paula Cortiñas, Indira Centeno
Objective: To evaluate if the COVID-19 vaccine produces changes in the menstrual pattern, type of change and dysmenorrhea. Methods: Observational and cross-sectional study. 6616 digital surveys were carried out on women who received a vaccine against COVID-19. A survey was applied via networks and in gynecological consultations. Percentages and 95 % confidence intervals were calculated from 2x2 tables, menstrual changes were analyzed in the sample and in subgroups according to type of vaccine, number of doses, age, and residence. Results: 86.5 % (3535/4087) reported menstrual changes, the most frequent being: menstrual delay (40.4 %) and heavier menstrual bleeding (37.7 %). Dysmenorrhea presented in 39 % accompanying menstrual changes, but 2.1 % as the only symptom. A statistically significant difference was observed: 1) more menstrual changes with mechanism of action chimpanzee viral vector when compared to inactivated virus, 2) human viral vector and inactivated virus more menstrual changes 18-34 years compared to 35-50 years and less changes when compared to chimpanzee viral vector in 35-50 years 3) mRNA was the least associated with menstrual absence when compared to human viral vector 53 % and chimpanzee 50 % more frequent. Conclusion: Menstrual changes are very common after vaccination against COVID-19, this being related to the type of vaccine administered. Some mechanisms of action seem to be related to a greater or lesser risk of specific menstrual changes.
{"title":"Cambios menstruales y dismenorrea posterior a las vacunas COVID-19. Estudio CAMVA-COVID-19","authors":"Katiuska Ríos Calderón, Yeiry González,, Mónica Elizabeth Cabrera-Sosa,, Linder Mariano Díaz Colmenarez, Yohaina Haddad, Rómely del Valle Blanco Salazar, Paula Cortiñas, Indira Centeno","doi":"10.51288/00830104","DOIUrl":"https://doi.org/10.51288/00830104","url":null,"abstract":"Objective: To evaluate if the COVID-19 vaccine produces changes in the menstrual pattern, type of change and dysmenorrhea. Methods: Observational and cross-sectional study. 6616 digital surveys were carried out on women who received a vaccine against COVID-19. A survey was applied via networks and in gynecological consultations. Percentages and 95 % confidence intervals were calculated from 2x2 tables, menstrual changes were analyzed in the sample and in subgroups according to type of vaccine, number of doses, age, and residence. Results: 86.5 % (3535/4087) reported menstrual changes, the most frequent being: menstrual delay (40.4 %) and heavier menstrual bleeding (37.7 %). Dysmenorrhea presented in 39 % accompanying menstrual changes, but 2.1 % as the only symptom. A statistically significant difference was observed: 1) more menstrual changes with mechanism of action chimpanzee viral vector when compared to inactivated virus, 2) human viral vector and inactivated virus more menstrual changes 18-34 years compared to 35-50 years and less changes when compared to chimpanzee viral vector in 35-50 years 3) mRNA was the least associated with menstrual absence when compared to human viral vector 53 % and chimpanzee 50 % more frequent. Conclusion: Menstrual changes are very common after vaccination against COVID-19, this being related to the type of vaccine administered. Some mechanisms of action seem to be related to a greater or lesser risk of specific menstrual changes.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47711473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The objective of this study was to determine the distribution of papillomavirus types in women with a confirmatory diagnosis with visual inspection with acetic acid (VIA). Methods: Women with positive cytology for intraepithelial lesion were included. Papillomavirus genotypes were analyzed using the Xpert® HPV system (GXHPV-CE-10) in conjunction with pathological cytology analysis of cervical tissue samples. Results: A prevalence of human papillomavirus infection of 61% was found, there was a correlation in age and the viral types detected with the P5 color channel (human papillomavirus 39, 56, 66, 68), age of the first sexual intercourse and human papillomavirus 18, number of pregnancies with P3 (human papillomavirus 31, 33, 35, 52, 58) and P5. The history of having a sexually transmitted infection was correlated with papillomavirus 18, P3, and P4 papillomavirus 51 and 59). In coinfection, a correlation was found between papillomavirus 16 genotypes with P3 (R: - 0.11), P4 (R: 0.22), and P5 (R: -0.14), with having had previous treatment (R: - 0.14). Papillomavirus 18 correlated with: P3 (R: 0.28). Conclusions: High-risk human papillomavirus typess 16, 18, and P3 were the most predominant in established cytological grades and among coinfected women.
{"title":"Genotipos de papiloma virus en mujeres de la selva peruana con inspección visual con ácido acético positivo","authors":"Anita Florian-Cáceres, S. Iglesias-Osores, Leila Marino-Panduro, Giancarlo Becerra- Atoche, Arturo Rafael-Heredia","doi":"10.51288/00830106","DOIUrl":"https://doi.org/10.51288/00830106","url":null,"abstract":"Objective: The objective of this study was to determine the distribution of papillomavirus types in women with a confirmatory diagnosis with visual inspection with acetic acid (VIA). Methods: Women with positive cytology for intraepithelial lesion were included. Papillomavirus genotypes were analyzed using the Xpert® HPV system (GXHPV-CE-10) in conjunction with pathological cytology analysis of cervical tissue samples. Results: A prevalence of human papillomavirus infection of 61% was found, there was a correlation in age and the viral types detected with the P5 color channel (human papillomavirus 39, 56, 66, 68), age of the first sexual intercourse and human papillomavirus 18, number of pregnancies with P3 (human papillomavirus 31, 33, 35, 52, 58) and P5. The history of having a sexually transmitted infection was correlated with papillomavirus 18, P3, and P4 papillomavirus 51 and 59). In coinfection, a correlation was found between papillomavirus 16 genotypes with P3 (R: - 0.11), P4 (R: 0.22), and P5 (R: -0.14), with having had previous treatment (R: - 0.14). Papillomavirus 18 correlated with: P3 (R: 0.28). Conclusions: High-risk human papillomavirus typess 16, 18, and P3 were the most predominant in established cytological grades and among coinfected women.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42177842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Núñez-Troconis, D. E. Carvallo Ruiz, E. M. Martínez Núñez
Malaria infections increase the risk of complications in the mother-fetus binomial. In Venezuela, the casuistry of this vulnerable group has not been updated in recent years. The objective of this narrative review was to comprehensively describe what pregnancy-associated malaria is and its maternal, fetal and neonatal effects; trying to answer the following research question. All forms of pregnancy-associated malaria, including gestational, placental and congenital malaria, cause maternal-fetal and neonatal alterations that, if they progress, could lead to the death of this binomial. Physiopathology and immunopathology can explain the symptoms of pregnant women and the fetus, as well as their complications; depending on the parasitic form affecting. There are new updates in the diagnosis, prevention and treatment of this entity.
{"title":"Malaria asociada al embarazo: revisión narrativa","authors":"J. Núñez-Troconis, D. E. Carvallo Ruiz, E. M. Martínez Núñez","doi":"10.51288/00830112","DOIUrl":"https://doi.org/10.51288/00830112","url":null,"abstract":"Malaria infections increase the risk of complications in the mother-fetus binomial. In Venezuela, the casuistry of this vulnerable group has not been updated in recent years. The objective of this narrative review was to comprehensively describe what pregnancy-associated malaria is and its maternal, fetal and neonatal effects; trying to answer the following research question. All forms of pregnancy-associated malaria, including gestational, placental and congenital malaria, cause maternal-fetal and neonatal alterations that, if they progress, could lead to the death of this binomial. Physiopathology and immunopathology can explain the symptoms of pregnant women and the fetus, as well as their complications; depending on the parasitic form affecting. There are new updates in the diagnosis, prevention and treatment of this entity.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49238363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kaelyn Rosa Sotomayor Valdiviezo Kaelyn Rosa Sotomayor Valdiviezo, Eliana Lizbet Valera Vásquez, Daniel Ángel Zavala Guillén, J. M. Vela-Ruiz, Joyce Desposorio-Robles,, María Del Socorro Alatrista Gutierrez De Bambarén
Objective: To conduct a review on mortality in pregnant women with COVID-19 during the 2020-2021 period in Latin America. Methods: A systematic review of scientific articles published from January 1, 2020 to December 31, 2021, was carried out in the Medline databases via PubMed, SciELO, Google Scholar. The question was: What is the mortality in pregnant women with COVID-19 during the 2020-2021 period in Latin America? through the controlled descriptors: “Pregnant women”, “COVID-19”, “Mortality”. Population: Pregnant women, Exposure: COVID-19, Outcome: Mortality. Results: One of the most vulnerable populations were pregnant women, as they are more susceptible to developing serious viral infections due to the physiological adaptations that occur during pregnancy. After the selection process, we included 10 studies that showed results. They were developed in pregnant women with a positive COVID-19 test and had a study population varying between 40 and 29,416 participants. Mortality in intensive care units was found to be 49% in Mexico City. A study in 8 Latin American countries reported that 86.4% of women were infected before delivery and 60.3% in the third trimester. Studies coincide in describing comorbidities in pregnant women with COVID-19, among which hypertensive disorders stand out. Conclusion: This study provides information about maternal mortality associated with COVID-19 among women in Latin America. In addition, pregnant women were found to present health barriers to accessing intensive care unit services.
{"title":"Mortalidad en gestantes con COVID - 19 durante el periodo 2020-2021 en Latinoamérica","authors":"Kaelyn Rosa Sotomayor Valdiviezo Kaelyn Rosa Sotomayor Valdiviezo, Eliana Lizbet Valera Vásquez, Daniel Ángel Zavala Guillén, J. M. Vela-Ruiz, Joyce Desposorio-Robles,, María Del Socorro Alatrista Gutierrez De Bambarén","doi":"10.51288/00830111","DOIUrl":"https://doi.org/10.51288/00830111","url":null,"abstract":"Objective: To conduct a review on mortality in pregnant women with COVID-19 during the 2020-2021 period in Latin America. Methods: A systematic review of scientific articles published from January 1, 2020 to December 31, 2021, was carried out in the Medline databases via PubMed, SciELO, Google Scholar. The question was: What is the mortality in pregnant women with COVID-19 during the 2020-2021 period in Latin America? through the controlled descriptors: “Pregnant women”, “COVID-19”, “Mortality”. Population: Pregnant women, Exposure: COVID-19, Outcome: Mortality. Results: One of the most vulnerable populations were pregnant women, as they are more susceptible to developing serious viral infections due to the physiological adaptations that occur during pregnancy. After the selection process, we included 10 studies that showed results. They were developed in pregnant women with a positive COVID-19 test and had a study population varying between 40 and 29,416 participants. Mortality in intensive care units was found to be 49% in Mexico City. A study in 8 Latin American countries reported that 86.4% of women were infected before delivery and 60.3% in the third trimester. Studies coincide in describing comorbidities in pregnant women with COVID-19, among which hypertensive disorders stand out. Conclusion: This study provides information about maternal mortality associated with COVID-19 among women in Latin America. In addition, pregnant women were found to present health barriers to accessing intensive care unit services.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42617664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To evaluate the effect of combined therapy in recurrent bacterial vaginosis in women from the Coffee Region (Colombia). Methods: Observational study, in 189 women over 18 years, diagnosed with recurrent bacterial vaginosis following the Nugent score. They were given combination therapy (oral induction with 500 mg metronidazole for seven days plus 600 mg vaginal boric acid once daily for twenty-one days, followed by 500 mg nifuratel and 200,000 IU vaginal nystatin for six days, every month, for six months); who attended consultation between 2017 and 2020. Clinical and laboratory follow-up was performed using Nugent’s score, one week after the end of oral treatment, at one month, three, six, nine and twelve months. Descriptive statistics were used. Results: The mean age of participants was 34.17 ± 5.31 years. The cure rate after initial therapy was 80.42% (at week), at month: 82.01 %, three months: 91.53 %, six: 90.47 %, nine: 90.47 % and at twelve months: 86.24 %. At the end of the study, the failure rate was 9.52%. There were no serious adverse events; the satisfaction rate was high (90.47 %). Conclusions: Combination therapy in recurrent bacterial vaginosis improved clinical and microbiological cure and decreased the risk of recurrence at twelve months follow-up. Validation of the present results is required in a randomized controlled clinical trial.
{"title":"Efecto de la terapia combinada en la vaginosis bacteriana recurrente en mujeres del Eje Cafetero, Colombia","authors":"Franklin José Espitia de la Hoz","doi":"10.51288/00830105","DOIUrl":"https://doi.org/10.51288/00830105","url":null,"abstract":"Objective: To evaluate the effect of combined therapy in recurrent bacterial vaginosis in women from the Coffee Region (Colombia). Methods: Observational study, in 189 women over 18 years, diagnosed with recurrent bacterial vaginosis following the Nugent score. They were given combination therapy (oral induction with 500 mg metronidazole for seven days plus 600 mg vaginal boric acid once daily for twenty-one days, followed by 500 mg nifuratel and 200,000 IU vaginal nystatin for six days, every month, for six months); who attended consultation between 2017 and 2020. Clinical and laboratory follow-up was performed using Nugent’s score, one week after the end of oral treatment, at one month, three, six, nine and twelve months. Descriptive statistics were used. Results: The mean age of participants was 34.17 ± 5.31 years. The cure rate after initial therapy was 80.42% (at week), at month: 82.01 %, three months: 91.53 %, six: 90.47 %, nine: 90.47 % and at twelve months: 86.24 %. At the end of the study, the failure rate was 9.52%. There were no serious adverse events; the satisfaction rate was high (90.47 %). Conclusions: Combination therapy in recurrent bacterial vaginosis improved clinical and microbiological cure and decreased the risk of recurrence at twelve months follow-up. Validation of the present results is required in a randomized controlled clinical trial.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41762290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hydatidosis is an anthropozoonosis caused by the larva of Echinococcus granulosus. The most affected organ is liver, followed by lungs, kidneys and osteo-muscular system. Generally, it has low progression and tend to be asymptomatic. The non-specific symptomatology makes diagnosis difficult and leads to unnecessary diagnostic procedures. Hydatid cysts of the female pelvic organs may initially be mistaken for ovarian cystic tumors or pelvic infections. This entity should be considered as a differential diagnosis of any pelvic cystic lesion in patients in endemic areas. Surgery is the standard of treatment and exploration of the abdominal cavity is essential in the search for cysts in other locations. Anthelmintic drugs may help decrease recurrence. A case of primary pelvic hydatidosis is presented.
{"title":"Hidatidosis pélvica primaria","authors":"Eduardo Reyna-Villasmil, Duly Torres-Cepeda, Martha Rondon-Tapia","doi":"10.51288/00830115","DOIUrl":"https://doi.org/10.51288/00830115","url":null,"abstract":"Hydatidosis is an anthropozoonosis caused by the larva of Echinococcus granulosus. The most affected organ is liver, followed by lungs, kidneys and osteo-muscular system. Generally, it has low progression and tend to be asymptomatic. The non-specific symptomatology makes diagnosis difficult and leads to unnecessary diagnostic procedures. Hydatid cysts of the female pelvic organs may initially be mistaken for ovarian cystic tumors or pelvic infections. This entity should be considered as a differential diagnosis of any pelvic cystic lesion in patients in endemic areas. Surgery is the standard of treatment and exploration of the abdominal cavity is essential in the search for cysts in other locations. Anthelmintic drugs may help decrease recurrence. A case of primary pelvic hydatidosis is presented.","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44915680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
El estudio del microbioma humano ha crecido de manera exponencial en la última década, y su importancia en el proceso de salud enfermedad del ser humano se hace cada vez más evidente. Se le ha implicado en múltiples enfermedades autoinmunes, inflamatorias, en cáncer, obesidad, síndrome metabólico y riesgo cardiovascular (1). La interacción que existe entre el ser humano y las comunidades de microorganismos que habitan en el cuerpo, es realmente compleja. Más de 1000 especies viven en este ecosistema. Los genomas de la microbiota, definidos como el microbioma, son más de 100 veces más grandes que el genoma humano (2). Únicamente en el intestino, se han caracterizado cientos de cepas bacterianas y más de 9 millones de genes que comprenden más de 3000 millones de células. Esto representa aproximadamente 0,5-2 kg del peso corporal total de cualquier individuo y es su misma diversidad, a la que se le ha implicado en muchas enfermedades que incluyen las esferas gastrointestinal, neurológica, autoinmunes e inflamatoria (1).
{"title":"Microbiota en la embarazada","authors":"Mireya González Blanco","doi":"10.51288/00820403","DOIUrl":"https://doi.org/10.51288/00820403","url":null,"abstract":"El estudio del microbioma humano ha crecido de manera exponencial en la última década, y su importancia en el proceso de salud enfermedad del ser humano se hace cada vez más evidente. Se le ha implicado en múltiples enfermedades autoinmunes, inflamatorias, en cáncer, obesidad, síndrome metabólico y riesgo cardiovascular (1). La interacción que existe entre el ser humano y las comunidades de microorganismos que habitan en el cuerpo, es realmente compleja. Más de 1000 especies viven en este ecosistema. Los genomas de la microbiota, definidos como el microbioma, son más de 100 veces más grandes que el genoma humano (2). Únicamente en el intestino, se han caracterizado cientos de cepas bacterianas y más de 9 millones de genes que comprenden más de 3000 millones de células. Esto representa aproximadamente 0,5-2 kg del peso corporal total de cualquier individuo y es su misma diversidad, a la que se le ha implicado en muchas enfermedades que incluyen las esferas gastrointestinal, neurológica, autoinmunes e inflamatoria (1).","PeriodicalId":35674,"journal":{"name":"Revista de Obstetricia y Ginecologia de Venezuela","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41999336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：